Insight Molecular Diagnostics Inc.
IMDX· Nasdaq
IMDXInsight Molecular Diagnostics Inc.
Filed Apr 16, 2024 · 10-K · 107 days after period end · 0001493152-24-014720
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $314.00K | $274.00K | $3.59M | $503.00K |
| Net Income | -$15.99M | -$44.98M | -$35.89M | -$6.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Apr 16, 2024 · 107 d after period end
